Switzerland considers Swiss franc intervention amid Iran war
Micron’s post-earnings dip won’t last, and the stock could bounce to new highs, charts show
FDA approves high dose version of Novo Nordisk’s obesity drug Wegovy
Final Fantasy 9 Long-Awaited Remake Has Gamers Marking Their Calendars
Eli Lilly’s new shot shows solid weight loss in study — plus, a way for Nvidia to perk up